Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Peter Clark, MA, MD, FRCP: A Payer Perspective

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Advertisement

Advertisement




Aug
11
Today In Oncology
Outreach to HCT Recipients, Primary Care Doctors May Reduce Skin Cancer Risk
American College of Surgeons Commission on Cancer Introduces Rural Cancer Program Accreditation
Phase III Trial Supports Intensified Total Neoadjuvant Therapy in High-Risk Rectal Cancer
Teclistamab Improves Progression-Free and Overall Survival in Previously Treated Multiple Myeloma
Oral Nicotinamide May Offer Cost-Effective Prevention of Keratinocyte Carcinoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo